Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (5)

2023

  1. Body composition and lung cancer-associated cachexia in TRACERx

    Nature Medicine, Vol. 29, Núm. 4, pp. 846-858

2021

  1. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

    The Lancet Diabetes and Endocrinology, Vol. 9, Núm. 8, pp. 491-501

2010

  1. Epithelial to Mesenchymal Transition Is Impaired in Colon Cancer Cells With Microsatellite Instability

    Gastroenterology, Vol. 138, Núm. 4, pp. 1406-1417

2009

  1. HIF-1α and HIF-2α have divergent roles in colon cancer

    International Journal of Cancer, Vol. 124, Núm. 4, pp. 763-771

2007

  1. Prevalence of Thyroid Cancer in Familial Adenomatous Polyposis Syndrome and the Role of Screening Ultrasound Examinations

    Clinical Gastroenterology and Hepatology, Vol. 5, Núm. 3, pp. 367-373